Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

BACKGROUND: Currently, adjuvant therapy is not recommended for patients with thoracic esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these patients go on to develop locoregional recurrence (LRR) within 2 years. Besides, there is no evidence for salvage chemoradiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xiao, Deng, Lei, Ni, Wenjie, Li, Chen, Han, Weiming, Gao, Lin-rui, Wang, Shijia, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Bi, Nan, Lv, Jima, Gao, Shugeng, Mao, Yousheng, Xue, Qi, Xiao, Zefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488997/
https://www.ncbi.nlm.nih.gov/pubmed/32928136
http://dx.doi.org/10.1186/s12885-020-07315-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488997/
https://www.ncbi.nlm.nih.gov/pubmed/32928136
http://dx.doi.org/10.1186/s12885-020-07315-0

Ejemplares similares